Motus GI Holdings will offer a follow-up to its initial public offering, including a proposed offering of 5,000,000 additional shares.
Here's what you should know:
1. Motus GI also granted its underwriters a 30-day option to purchase up to 750,000 shares.
2. Piper Jaffray & Co. is the only underwriter for the additional offering.
3. Motus GI will use the funds for commercializing the Pure-Vu System,a colonoscopy prep alternative.
More articles on gastroenterology:
A's slugger Matt Chapman undergoes shoulder procedure at Bass Surgical Center — 4 insights
Envision, UnitedHealthcare agree to extend payer contract & more — 7 ASC company key notes
MBRE Healthcare acquires Colorado medical office building with surgery center for $26.6M — 3 insights